2021
Extended Use of the Control-IQ Closed-Loop Control System in Children With Type 1 Diabetes.
Kanapka LG, Wadwa RP, Breton MD, Ruedy KJ, Ekhlaspour L, Forlenza GP, Cengiz E, Schoelwer MJ, Jost E, Carria L, Emory E, Hsu LJ, Weinzimer SA, DeBoer MD, Buckingham BA, Oliveri M, Kollman C, Dokken BB, Cherñavvsky D, Beck RW. Extended Use of the Control-IQ Closed-Loop Control System in Children With Type 1 Diabetes. Diabetes Care 2021, 44: 473-478. PMID: 33355258, PMCID: PMC7818334, DOI: 10.2337/dc20-1729.Peer-Reviewed Original ResearchConceptsType 1 diabetesChildren 6Sensor-Augmented Pump TherapyWeeks of useDiabetic ketoacidosisDays of useGlycemic controlSAP groupSevere hypoglycemiaPump therapyClinical trialsPercentage of timeCLC groupMean TIRDiabetesFurther evaluationCohortRCTsDlWeeksChildrenDaysExtended useParticipantsKetoacidosis
2011
Successful Lung Retransplantation After Extended Use of Extracorporeal Membrane Oxygenation as a Bridge
Shigemura N, Bermudez C, Bhama J, Bonde P, Thacker J, Toyoda Y. Successful Lung Retransplantation After Extended Use of Extracorporeal Membrane Oxygenation as a Bridge. Transplantation Proceedings 2011, 43: 2063-2065. PMID: 21693326, DOI: 10.1016/j.transproceed.2011.02.008.Peer-Reviewed Original ResearchConceptsEarly allograft dysfunctionExtracorporeal membrane oxygenationLung transplantationAllograft dysfunctionMembrane oxygenationRedo lung transplantationAcute cellular rejectionDouble lung transplantationSingle lung transplantationMajor clinical challengeCellular rejectionLung retransplantationClinical challengeSuccessful outcomeTransplantationPatientsDysfunctionOxygenationSuccessful useExtended useRetransplantation
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply